Avalo Therapeutics, Inc. - Common Stock (AVTX)
CUSIP: 05338F306
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 22,946,429
- Total 13F shares
- 15,317,685
- Share change
- +7,474,645
- Total reported value
- $194,685,792
- Put/Call ratio
- 46%
- Price per share
- $12.71
- Number of holders
- 65
- Value change
- +$95,069,684
- Number of buys
- 47
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 05338F306?
CUSIP 05338F306 identifies AVTX - Avalo Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05338F306:
Institutional Holders of Avalo Therapeutics, Inc. - Common Stock (AVTX) as of Q3 2025
As of 30 Sep 2025,
Avalo Therapeutics, Inc. - Common Stock (AVTX) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,317,685 shares.
The largest 10 holders included
BVF INC/IL, ORBIMED ADVISORS LLC, Nantahala Capital Management, LLC, Point72 Asset Management, L.P., Affinity Asset Advisors, LLC, Caligan Partners LP, Balyasny Asset Management L.P., SILVERARC CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and RA CAPITAL MANAGEMENT, L.P..
This page lists
65
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
35
Q3 2025 holders
65
Holder diff
30
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.